Search research articles
Contact Us
Filters
Showing results (11-20 of 51) with videos related to
Page
of 6
Sort By:
Journal of Neuro-Oncology
|
June 19, 2024
A novel methylation signature predicts extreme long-term survival in glioblastoma
Brecht Decraene, Grégoire Coppens, Lien Spans, et al.
Journal of Clinical Microbiology
|
April 22, 2011
Actinobaculum schaalii causing Fournier's gangrene
Isabelle Vanden Bempt, Stefanie Van Trappen, Ilse Cleenwerck, et al.
The Journal of Molecular Diagnostics : JMD
|
February 23, 2024
Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic Purposes
Jef Baelen, Barbara Dewaele, Maria Debiec-Rychter, et al.
Journal of Cancer Research and Clinical Oncology
|
May 15, 2023
Therapeutic yield of extensive molecular profiling in cholangiocarcinoma: a retrospective single-center study
Justine Vancanneyt, Bie Wilmsen, Caroline Luyten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2008
Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing
Isabelle Vanden Bempt, Peter Van Loo, Maria Drijkoningen, et al.
Oncology Research and Treatment
|
April 25, 2021
Curative, Organ-Sparing, Multimodal, Perioperative Treatment of a Young Patient with a Rectoanal Inflammatory Myofibroblastic Tumor
Patrick Schöffski, Sara Vander Borght, Isabelle Vanden Bempt, et al.
Clinical Journal of Gastroenterology
|
August 9, 2025
Malignant triton tumor of the common bile duct
Alexander Dumarey, Cleo Bertels, Ann Reekmans, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 4, 2022
Targeted RNA sequencing for upfront analysis of actionable driver alterations in non-small cell lung cancer
Sofie Claerhout, Stefan Lehnert, Sara Vander Borght, et al.
Cancer Research
|
July 20, 2007
The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor /progesterone receptor /HER-2 breast carcinomas
Lieve Verlinden, Isabelle Vanden Bempt, Guy Eelen, et al.
Clinical Drug Investigation
|
January 15, 2019
Correction to: Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer
Griet Hoste, Laurence Slembrouck, Lynn Jongen, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 51) with videos related to
Sort By:
Page
of 6
Journal of Neuro-Oncology
|
June 19, 2024
A novel methylation signature predicts extreme long-term survival in glioblastoma
Brecht Decraene, Grégoire Coppens, Lien Spans, et al.
Journal of Clinical Microbiology
|
April 22, 2011
Actinobaculum schaalii causing Fournier's gangrene
Isabelle Vanden Bempt, Stefanie Van Trappen, Ilse Cleenwerck, et al.
The Journal of Molecular Diagnostics : JMD
|
February 23, 2024
Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic Purposes
Jef Baelen, Barbara Dewaele, Maria Debiec-Rychter, et al.
Journal of Cancer Research and Clinical Oncology
|
May 15, 2023
Therapeutic yield of extensive molecular profiling in cholangiocarcinoma: a retrospective single-center study
Justine Vancanneyt, Bie Wilmsen, Caroline Luyten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2008
Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing
Isabelle Vanden Bempt, Peter Van Loo, Maria Drijkoningen, et al.
Oncology Research and Treatment
|
April 25, 2021
Curative, Organ-Sparing, Multimodal, Perioperative Treatment of a Young Patient with a Rectoanal Inflammatory Myofibroblastic Tumor
Patrick Schöffski, Sara Vander Borght, Isabelle Vanden Bempt, et al.
Clinical Journal of Gastroenterology
|
August 9, 2025
Malignant triton tumor of the common bile duct
Alexander Dumarey, Cleo Bertels, Ann Reekmans, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 4, 2022
Targeted RNA sequencing for upfront analysis of actionable driver alterations in non-small cell lung cancer
Sofie Claerhout, Stefan Lehnert, Sara Vander Borght, et al.
Cancer Research
|
July 20, 2007
The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor /progesterone receptor /HER-2 breast carcinomas
Lieve Verlinden, Isabelle Vanden Bempt, Guy Eelen, et al.
Clinical Drug Investigation
|
January 15, 2019
Correction to: Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer
Griet Hoste, Laurence Slembrouck, Lynn Jongen, et al.
Page
of 6